Research analysts at StockNews.com started coverage on shares of Global Cord Blood (NYSE:CO – Get Free Report) in a research note issued to investors on Sunday. The brokerage set a “strong-buy” rating on the medical research company’s stock.
Global Cord Blood Price Performance
Shares of Global Cord Blood stock opened at $1.75 on Friday. The firm has a market cap of $212.71 million, a P/E ratio of 2.73 and a beta of 0.16. The business has a 50-day moving average price of $1.31 and a 200 day moving average price of $1.37. Global Cord Blood has a fifty-two week low of $2.03 and a fifty-two week high of $5.50.
About Global Cord Blood
See Also
- Five stocks we like better than Global Cord Blood
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Moderna Dips on Q2 Earnings But Can It Rip on a Short Squeeze?
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- 2 Option Strategies to Maximize Profits in a Bear Market
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Lululemon Stock Gears Up for a Massive Comeback Rally
Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.